These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 526011)

  • 21. Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs.
    Alenius S; Oberg B
    Arch Virol; 1978; 58(4):277-88. PubMed ID: 736794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapeutic efficacy of E-5-(2-bromovinyl)-2'deoxyuridine for orofacial infection with herpes simplex virus type 1 in mice.
    Park NH; Pavan-Langston D; Boisjoly HM; De Clercq E
    J Infect Dis; 1982 Jun; 145(6):909-13. PubMed ID: 6979592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals.
    Boyd MR; Bacon TH; Sutton D
    Antimicrob Agents Chemother; 1988 Mar; 32(3):358-63. PubMed ID: 3364954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on the acute local phase of herpes simplex virus-induced skin infections in mice and the establishment of latency.
    Klein RJ; Friedman-Kien AE
    Antimicrob Agents Chemother; 1985 May; 27(5):763-8. PubMed ID: 3874596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xylotubercidin against herpes simplex virus type 2 in mice.
    De Clercq E; Robins MJ
    Antimicrob Agents Chemother; 1986 Nov; 30(5):719-24. PubMed ID: 3800347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
    Klein RJ; Friedman-Kien AE; Yellin PB
    Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneously applied acyclovir acts systemically in the treatment of herpetic infection in the hairless mouse.
    Bolger GT; Allen T; Garneau M; Lapeyre N; Liard F; Jaramillo J
    Antiviral Res; 1997 Aug; 35(3):157-65. PubMed ID: 9298755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.
    Alenius S; Dinter Z; Oberg B
    Antimicrob Agents Chemother; 1978 Sep; 14(3):408-13. PubMed ID: 213015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effect of pyrophosphate analogues on cutaneous herpes simplex virus type 1 infection in guinea pigs.
    Wutzler P; Helbig B; Ulbricht A; Meerbach A; Pradel W
    Antiviral Res; 1988 Nov; 10(1-3):99-106. PubMed ID: 2852923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig.
    Burkhardt U; Wigand R
    J Med Virol; 1983; 12(2):137-47. PubMed ID: 6194252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
    Poryo A; Wigand R
    Med Microbiol Immunol; 1984; 173(4):219-24. PubMed ID: 6096685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of herpes simplex virus infection by phosphonoacetic acid.
    Shipkowitz NL; Bower RR; Appell RN; Nordeen CW; Overby LR; Roderick WR; Schleicher JB; Von Esch AM
    Appl Microbiol; 1973 Sep; 26(3):264-7. PubMed ID: 4356456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice.
    Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K
    Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iontophoretic application of adenine arabinoside monophosphate for the treatment of herpes simplex virus type 2 skin infections in hairless mice.
    Kwon BS; Hill JM; Wiggins C; Tuggle C
    J Infect Dis; 1979 Dec; 140(6):1014. PubMed ID: 94335
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of 5,6-dihydro-5-azathymidine against cutaneous herpes simplex virus in hairless mice.
    Underwood GE; Weed SD
    Antimicrob Agents Chemother; 1977 Apr; 11(4):765-7. PubMed ID: 856033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice.
    Docherty JJ; Smith JS; Fu MM; Stoner T; Booth T
    Antiviral Res; 2004 Jan; 61(1):19-26. PubMed ID: 14670590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.
    Klein RJ; Friedman-Kien AE; Fondak AA; Buimovici-Klein E
    Infect Immun; 1977 Jun; 16(3):842-8. PubMed ID: 197008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium hypochlorite in the treatment of herpes simplex virus infections.
    Hunter DT
    Cutis; 1983 Mar; 31(3):328-32. PubMed ID: 6682365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.